Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts (Q38477506)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2008
edit
Language Label Description Also known as
English
Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts
scientific article published on July 2008

    Statements

    Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts (English)
    James E Littlejohn
    Xiaobo Cao
    Steven D Miller
    Mustafa K Ozvaran
    Daniel Jupiter
    Lidong Zhang
    Charles Rodarte
    W Roy Smythe
    1 July 2008
    202-208

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit